Clinical Trials List
2023-10-15 - 2029-09-07
Phase II
Not yet recruiting3
ICD-10G30.0
Alzheimer's disease with early onset
ICD-10G30.1
Alzheimer's disease with late onset
ICD-10G30.8
Other Alzheimer's disease
ICD-10G30.9
Alzheimer's disease, unspecified
ICD-9331.0
Alzheimer's disease
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Hsiu-Chuan Wu Division of Neurology
- Chi-Hung Liu Division of Neurology
- Kun-Ju Lin Division of Nuclear Medicine
- KuoLun Huang Division of Neurology
- 張庭瑜 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃啟維 Division of Neurology
- 黃淑華 Division of Nuclear Medicine
- Hong jie Chen Division of Nuclear Medicine
- 許世偉 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 張維紘 Division of Neurology
- Wei-Pin Hong Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6-10 participants
-
Global
365 participants
